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Living as a commensal, Candida albicans must adapt and respond to environmental cues generated by the
mammalian host and by microbes comprising the natural flora. These signals have opposing effects on C.
albicans, with host cues promoting the yeast-to-hyphal transition and bacteria-derived quorum-sensing mol-
ecules inhibiting hyphal development. Hyphal development is regulated through modulation of the cyclic AMP
(cAMP)/protein kinase A (PKA) signaling pathway, and it has been postulated that quorum-sensing molecules
can affect filamentation by inhibiting the cAMP pathway. Here, we show that both farnesol and 3-oxo-C12-
homoserine lactone, a quorum-sensing molecule secreted by Pseudomonas aeruginosa, block hyphal develop-
ment by affecting cAMP signaling; they both directly inhibited the activity of the Candida adenylyl cyclase,
Cyr1p. In contrast, the 12-carbon alcohol dodecanol appeared to modulate hyphal development and the cAMP
signaling pathway without directly affecting the activity of Cyr1p. Instead, we show that dodecanol exerted its
effects through a mechanism involving the C. albicans hyphal repressor, Sfl1p. Deletion of SFL1 did not affect
the response to farnesol but did interfere with the response to dodecanol. Therefore, quorum sensing in C.
albicans is mediated via multiple mechanisms of action. Interestingly, our experiments raise the possibility that
the Burkholderia cenocepacia diffusible signal factor, BDSF, also mediates its effects via Sfl1p, suggesting that
dodecanol’s mode of action, but not farnesol or 3-oxo-C12-homoserine lactone, may be used by other quorum-
sensing molecules.
Candida albicans is an opportunistic fungal pathogen of hu-
mans. In healthy individuals C. albicans resides in the gastro-
intestinal, vaginal, and oral tracts, where it is considered to be
part of the normal flora. However, when an individual becomes
immunocompromised as a consequence of age, cancer, chemo-
therapy, or trauma, C. albicans is able to invade the underlin-
ing mucosal surface and disseminate into the bloodstream
causing systemic disease. Mortality rates associated with sys-
temic candidiasis are reported to be 30% higher than those
associated with bacterial infections. Thus, C. albicans is a med-
ically relevant microbial pathogen (reviewed in references 2,
28, and 32).
The ability of C. albicans to undergo a morphological tran-
sition from yeast to hyphal forms is essential for virulence, with
strains locked in either form displaying attenuated virulence in
models for systemic candidiasis (35). This switch in morphol-
ogy is governed by many host environmental signals acting
through several well-established signaling cascades including
the CEK1 mitogen-activated protein kinase (MAPK) pathway,
the RIM101-dependent pathway, and the cAMP-dependent
protein kinase A (cAMP/PKA) pathway (10, 27, 42). The
cAMP/PKA pathway appears to be the most essential for mor-
phogenesis, with an adenylyl cyclase mutant being defective for
filamentation in response to the majority of stimulating cues
(45).
In addition to host environmental signals, C. albicans must
also adapt and respond to microorganisms from the microflora
to successfully establish itself within a niche. Microorganisms
communicate by a process known as quorum sensing (QS),
where soluble chemical mediators termed quorum-sensing
molecules (QSMs) or autoinducers (AIs) are secreted into the
environment in a cell density-dependent manner (reviewed in
references 23 and 50). Two distinct QSMs, the C. albicans
self-generated sesquiterpene farnesol and the Pseudomonas
aeruginosa secreted 3-oxo-C12-homoserine lactone (HSL), in-
hibit the yeast-to-hyphal transition in C. albicans morphogen-
esis (24, 25). Farnesol and 3-oxo-C12-HSL both contain a
12-carbon backbone, and they both appear to influence mor-
phogenesis by inhibiting the Candida cAMP/PKA pathway
(11). Dodecanol, a 12-carbon alcohol which is not a physiolog-
ically relevant QSM, also has activity against C. albicans fila-
mentation (24), and it, too, appears to inhibit the cAMP/PKA
pathway (11). Due to their similarities, dodecanol is routinely
used as a substitute for 3-oxo-C12-HSL (11, 24). However, the
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exact mechanism by which these QSMs mediate their effects on
C. albicans remains unknown. For example, additional path-
ways, including the MAPK- and Tup1p-dependent signaling
cascades, have also been shown to play a role in QS (26, 46),
suggesting that there is a considerable amount of cross talk
between the systems or that QSMs can inhibit multiple pro-
cesses contributing to filamentation.
Here, we demonstrate that farnesol, 3-oxo-C12-HSL, and
dodecanol regulate morphogenesis in C. albicans through in-
dependent mechanisms mediated via the cAMP-dependent
signaling cascade. Farnesol and 3-oxo-C12-HSL directly inhibit
the adenylyl cyclase, Cyr1p, while dodecanol prevents cAMP-
dependent hyphal development through a process dependent
upon the transcriptional repressor SFL1. Dodecanol may serve
as a model for the action of other quorum-sensing molecules,
including the Burkholderia cenocepacia diffusible signal factor
BDSF, also acting via Sfl1p.
MATERIALS AND METHODS
Strains and media. C. albicans strains were maintained as glycerol stocks at
80°C and cultured on YPD medium (1% yeast extract, 1% Bacto peptone, 2%
glucose, 2% agar) when required. Strains used for quorum-sensing assays were
never more than 10 days old. To identify C. albicans components that are
involved in mediating its response to QSMs, we systematically screened a C.
albicans knockout library for strains with altered responses to either 150 M
farnesol (mixed isomers; Sigma F203) or 200 M dodecanol (Sigma) in a plate-
based filamentation assay (see below). This library consisted of 158 C. albicans
nonessential transcription factor mutants (provided by D. Sanglard). The gene
deletions in the library were constructed in the BWP17 strain either by UAU
transposon mutagenesis (8), URA-blaster (16), or HIS3/ARG4 cassette technol-
ogies (17). Strain BWP17AHU was used as the parental control for these strains
(20); other strains are listed in Table 1.
Quorum-sensing assays were performed on Dulbecco’s modified Eagle me-
dium ([DMEM] 1.34% DMEM [Gibco], 3.57% HEPES supplemented to a final
concentration of 2% glucose, pH 7) without bicarbonate and pyruvate and
supplemented with 5% horse serum and either 150 M farnesol (mixed isomer)
or 200 M dodecanol. Higher concentrations of QSMs were required to inhibit
hypha formation due to the sequestering effects of the albumin, as previously
reported (41). QSMs were diluted in 100% methanol (farnesol and dodecanol)
or ethyl acetate (C12-HSL; Sigma) immediately prior to addition to the media.
For cAMP spiking experiments, dibutyryl-cAMP (dbcAMP) was supplemented
into DMEM agar to a final concentration of 10 mM. In brief, colonies from fresh
YPD agar were serially diluted in water to the desired cell concentration and
plated onto the plates to generate single colonies. Plates were incubated at 37°C
for 24 h. Where CO2 was used to induce morphogenesis, strains were plated onto
DMEM agar supplemented with methanol, 150 M farnesol, and 200 M do-
decanol and incubated at 37°C in 5% (vol/vol) CO2.
Plasmid and strain construction. The URA3 integration vector pSM2 (13) was
used to complement uridine auxotrophies and was the base vector for the gen-
eration of integration cassettes. Integration of the cassettes was confirmed by
diagnostic PCR, and expression levels were analyzed by reverse transcription-
PCR (RT-PCR) (data not shown). To complement CAL2 (sfl1 ura3) with a
single copy of SFL1, a 4.4-kb fragment including the complete open reading
frame of SFL1, 1.3 kb of upstream sequence, and 556 bp of downstream se-
quence was amplified from genomic DNA using the primers 5-ggagaggcggccgc
CTTTGCGCAGGAAATAGAGAAAG and 5-ggagaggcggccgcCCAAGATTA
TAAATCGATTGCAT (lowercase indicates introduced restriction enzymes)
and ligated into the pSM2 vector as an NotI fragment generating plasmid pSM2-
SFL1. pSM2-SFL1 was integrated into the URA3 locus of CAL2 by standard heat
shock procedures (55) generating strain RAH41.
To generate Sfl1p as a C-terminally tagged green fluorescent protein (GFP)
fusion protein, GFP together with 60 bp of the ADH1 terminator was cleaved
from the pGFP vector (4) as a SpeI-BamHI fragment and ligated into the C.
albicans URA3 integration vector, pSM2, to generate plasmid pGFP-RH. The
open reading frame of SFL1 (minus stop codon), including 1.3 kb of its native
promoter, was cloned into the pGFP-RH plasmid as an NotI-SpeI fragment
generating plasmid pGFP-Sfl1, which was integrated at the URA3 locus of CAL2,
generating strain RAH42.
Activity testing of Cyr1p. A fragment encoding amino acids 1166 to 1571
(containing the catalytic domain) of C. albicans Cyr1p was purified, and the
catalytic activity was measured in the absence/presence of QSMs or alternative
12-carbon compounds as previously described (27). In brief, 100 ng of purified
protein was incubated with the QSMs or solvent control in the presence of 50
mM Tris-HCl (pH 7.5), 10 mM ATP, and 10 mM MgCl2 and the indicated
concentrations of NaHCO3 in a final volume of 100 l. Reaction mixtures were
incubated at 30°C for 30 min and stopped by the addition of 100 l of 0.2 N HCl.
The produced cAMP was measured as previously described (22) by a Correlate-
EIA Direct cAMP enzyme immunoassay kit (Assay Designs), and data analyses
were performed with GraphPad Prism, version 4.0a.
Localization of Sfl1p. RAH42 was grown in yeast nitrogen base (YNB) me-
dium (0.67% YNB without amino acids with ammonium sulfate [Difco], 2%
sterile filtered glucose) for 16 h at 30°C and 150 rpm and diluted (optical density
at 600 nm [OD600] of 0.1) in fresh YNB (yeast) and YNB medium supplemented
with 5% horse serum (hyphae) and grown at 37°C and 150 rpm until mid-
exponential phase (OD600 of 0.6); then, 1 g/ml of 4,6-diamidino-2-phenylin-
dole (DAPI) was added to the culture, which was incubated for a further 20 min.
Then cells were harvested by centrifugation and washed three times with water.
Cells were visualized using an Olympus IX-81 fluorescence microscope with a
150-W xenon-mercury lamp and an Olympus 150 Plan NeoFluor oil immersion
objective. To determine the effects of QSMs on Sfl1p localization, cultures were
supplemented with 150 M farnesol and 200 M dodecanol.
Coincubation of B. cenocepacia and C. albicans. A total of 500 cells of C.
albicans strains BWP17AHU, RAH40, and RAH41 were plated onto DMEM
agar (pH 7) supplemented with 5% horse serum. Ten microliters of a 10-times-
concentrated overnight culture (OD600 of 30) of B. cenocepacia strain J2315 (a
cystic fibrosis clinical isolate [18]) was spotted onto the center of each plate, and
the plate was incubated at 37°C for 24 h. Images were taken of C. albicans strains
in close proximity to the B. cenocepacia and at distal sites.
Hydrogen peroxide sensitivity assay. BWP17AHU, RAH40, and RAH41 were
grown in YNB medium at 30°C for 16 h and then inoculated into 50 ml of YPD
medium (containing a volume of methanol equivalent to that used to dissolve the
QSMs) or YPD medium supplemented with either 50 M farnesol or 66 M
dodecanol to an initial OD600 of 0.1. After 10 min of growth at 37°C, 5% horse
serum was added to the cultures, and samples were incubated at 37°C for 2 h.
Then, cultures were split into two equal volumes and centrifuged for 5 min at
3,500 rpm before being resuspended in 5 ml of YPD medium or 5 ml of YPD
medium supplemented with 10 mM H2O2 and incubated at 30°C for 90 min.
Cells were harvested by centrifugation (5 min at 3,500 rpm) and resuspended in
25 ml of water; then 50 l of 1:100 and 1:1,000 dilutions was plated onto YPD
medium. The number of CFU was determined after 24 h of incubation at 37°C.
Semiquantitative RT-PCR. Overnight cultures of BWP17AHU in YPD me-
dium were diluted in fresh YPD medium supplemented with 5% horse serum in
the presence of either methanol (a volume equal to that used to dissolve QSM),
150 M farnesol, or 200 M dodecanol to an OD600 of 0.1. Cultures were grown
at 37°C and 200 rpm for 4 h. Cells were harvested by centrifugation (5 min at
3,500 rpm) and immediately frozen in liquid nitrogen. Samples were homoge-
TABLE 1. Strains used in this study
Strain Genotype Reference or source
BWP17AHU ura3::imm434/URA3 arg4::hisG/ARG4 his1::hisG/HIS1 20
CAL2 ura3::imm434/ura3::imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG sfl1::ARG4/sfl1::HIS1 33
RAH20 ura3::imm434/ura3::imm434 cyr1::hisG/cyr1::hisG (pSM2) 21
RAH40 ura3::imm434/ura3::imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG sfl1::ARG4/sfl1::HIS1 (pSM2) This study
RAH41 ura3::imm434/ura3::imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG sfl1::ARG4/sfl1::HIS1 (pSM2-SFL1) This study
RAH42 ura3::imm434/ura3::imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG sfl1::ARG4/sfl1::HIS1 (pGFP-SFL1) This study
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nized using a Mikro dismembrator (2 min, 3,000 rpm), and total was RNA
extracted with a Qiagen RNeasy kit following the recommended protocol for
filamentous fungi. RT-PCR was performed with an iScript One-step RT-PCR kit
with Sybr Green (Bio-Rad) using 30 ng of total RNA according to the manu-
facturer’s recommendations. SFL1 was amplified with the primers (annealing
temperature, 58°C) SFL1-F (TCAACACCAACTCACCCACCTACA) and
SFL1-R (GTTGATTCGGCTCGATTGCGGAAA), and levels were normalized
to ACT1.
RESULTS
Exogenous cAMP inhibits quorum sensing in response to
physiological stimuli. It has been previously shown that mem-
brane-permeable cAMP (dbcAMP) can restore N-acetylgluco-
samine-induced hyphal formation in the presence of farnesol
(11). To determine whether exogenous cAMP could also re-
store the filamentation response to host environmental signals
blocked by QSMs, C. albicans was grown in medium containing
5% serum in the presence of farnesol and C12-HSL. Supple-
mentation of medium with dbcAMP restored filamentation
(Fig. 1A), confirming that exogenous cAMP can restore hyphal
formation in response to host environmental cues.
As farnesol is hydrophobic, it is possible that it associates
with cell membranes (51). Ras1p, a small GTPase usually at-
tached to the cell membrane by a palmitoyl lipid moiety (36),
is an essential component of both the MAPK and cAMP/PKA
signaling cascades (15, 31). Therefore, one possible mode of
action for farnesol-mediated inhibition of hyphal formation is
that farnesol prevents Ras1p from dissociating from the mem-
brane to activate downstream effectors (11, 40). To test this
hypothesis, we explored the ability of farnesol to inhibit CO2-
mediated hyphal induction. CO2 is also a host environmental
factor which is a potent inducer of C. albicans morphogenesis;
it has been shown to activate the cAMP/PKA cascade through
carbonic anhydrase-dependent conversion into bicarbonate,
which directly modulates the activity of the Candida adenylyl
cyclase, Cyr1p (21, 27). Farnesol and dodecanol were able to
inhibit CO2-mediated hyphal development when supple-
mented into the medium at the same concentrations as those
used for other hypha-inducing cues (Fig. 1B and C). As Ras1p
activity is not required for CO2 induced morphogenesis (27),
we conclude that farnesol and dodecanol are able to exert their
effects through the cAMP signaling pathway but via methods
other than inhibiting Ras1p activity.
Dodecanol enhances C. albicans resistance to oxidative
stress. Previously, it has been shown that exposure to farnesol
can enhance oxidative stress resistance of C. albicans (12, 57).
To identify whether dodecanol is also able to induce oxidative
stress resistance, we pretreated exponentially growing C. albi-
cans cells with dodecanol prior to exposing the cells to oxida-
tive stress. Addition of dodecanol resulted in a 2.6-fold in-
crease in stress resistance, similar to that observed for farnesol
(Fig. 2). Therefore, both farnesol and dodecanol can enhance
C. albicans oxidative stress resistance.
Farnesol and 3-oxo-C12-HSL, but not dodecanol, directly
target Cyr1p. The adenylyl cyclase Cyr1p is an environmental
multisensor that directly responds to host environmental cues,
including serum, peptidoglycan, and elevated CO2 through
different protein domains (14, 21, 27, 58). As the effects of
quorum sensing in C. albicans occur through inhibition of
cAMP signaling cascades and as addition of exogenous cAMP
is sufficient to restore hyphal development (11), we decided to
test whether QSMs directly target Cyr1p. While full-length,
native Cyr1p has proven to be recalcitrant to purification, trun-
cated recombinant Cyr1p (amino acids [aa]1166 to 1571) con-
sisting almost exclusively of the catalytic domain has been
successfully purified and was previously shown to be responsive
FIG. 1. Farnesol, C12-HSL, and dodecanol modulate the cAMP/
PKA pathway to inhibit morphogenesis in response to host environ-
mental conditions. (A) C. albicans was inoculated onto DMEM agar,
pH 7, supplemented with 5% horse serum and grown in the presence
of methanol (vehicle control), 150 M farnesol, 150 M farnesol
supplemented with 10 mM dbcAMP, ethyl acetate (vehicle control),
200 M C12-HSL, and 200 M C12-HSL supplemented with 10 mM
dbcAMP and incubated at 37°C for 24 h. Scale bar, 500 m. (B) C.
albicans was inoculated onto DMEM agar, pH 7, supplemented with
5% CO2 in the presence of methanol (vehicle control), 150 M farne-
sol, and 150 M farnesol supplemented with 10 mM dbcAMP and
incubated at 37°C for 24 h. Scale bar, 500 m. (C) C. albicans was
resuspended in water, serially diluted to obtain 200 CFU/plate, and
incubated on DMEM agar, pH 7, supplemented with either methanol
or 200 M dodecanol in the presence of 5% horse serum or 5% CO2
and incubated at 37°C for 16 h. Scale bar, 100 m.
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to environmental concentrations of CO2 (27). This recombi-
nant Cyr1p protein was directly inhibited by farnesol, with the
bioactive (E,E) isomer displaying three times more potency
than the isomeric mixture (50% inhibitory concentration [IC50]
of 17 M versus 60 M) (Fig. 3A). These data strongly suggest
that farnesol mediates its quorum-sensing effects by directly
inhibiting the activity of Cyr1p.
To determine whether farnesol inhibition is a general prop-
erty of bicarbonate-responsive adenylyl cyclases, we tested
both the mammalian and the cyanobacterial soluble adenylyl
cyclase (sAC), CyaC. Neither of the two bicarbonate-respon-
sive sACs was inhibited by farnesol (at concentrations up to
250 M) (Fig. 3E and F). Therefore, farnesol inhibition is a
unique property of the C. albicans adenylyl cyclase, Cyr1p.
As CO2 and farnesol directly impact on Cyr1p activity, the
relationship between them was investigated. Farnesol and bi-
carbonate noncompetitively interacted with Cyr1p (Fig. 3D),
suggesting that although they both bind within the catalytic
domain, they bind different sites. In agreement with this, the
strain CAI4-CYR11373, which has previously been shown to
have reduced response to CO2 (21), was fully responsive to
farnesol (data not shown). Therefore, QSMs bind to the cata-
lytic domain of Cyr1p at a site distal to that of the CO2 binding
site.
The QSM secreted by P. aeruginosa, 3-oxo-C12-HSL, also
inhibits hyphal development in C. albicans (24). Therefore, we
tested whether this QSM also inhibits the catalytic activity of
Cyr1p. The commercially available bioactive analogue, C12 ho-
moserine lactone (C12-HSL), directly inhibited the activity of
recombinant Cyr1p (IC50 of 90 M) (Fig. 3B). Therefore, we
propose that farnesol and 3-oxo-C12-HSL mediate their effects
by directly inhibiting the activity of Cyr1p, hence blocking the
cAMP signaling response to environmental stimuli.
Farnesol and 3-oxo-C12-HSL share structural similarity; they
FIG. 2. Farnesol and dodecanol enhance C. albicans oxidative
stress resistance. C. albicans (BWP17AHU; wild type) was grown in
YPD medium and 5% serum supplemented with solvent alone, 50 M
farnesol, or 66 M dodecanol. Cultures were split in two, and one set
was exposed to 10 mM H2O2 for 90 min, while the other set was
maintained at 37°C. CFU were counted to determine cell survival, and
data are expressed as percent survival of the untreated control sam-
ples. , P  0.05.
FIG. 3. Farnesol and 3-oxo-C12-homoserine lactone directly inhibit Cyr1p but not other soluble adenylyl cyclases. The activity of purified
recombinant C. albicans Cyr1p (fragment encoding amino acids 1166 to 1571) was assayed with 5 mM ATP and 5 mM MgCl2 in the presence of
the indicated concentrations of farnesol [f, (E,E)-farnesol; Œ, isomeric mixture of farnesol] (A), C12-HSL (B), dodecanol (C), and of various
bicarbonate concentrations [f, solvent control; Œ,16.65 M E,E-farnesol; }, 50 M E,E-farnesol] (D). (E) Activity of purified glutathione
S-transferase (GST)-truncated rat sAC, in the presence of E,E-farnesol. (F) Activity of purified CyaC in the presence of E,E-farnesol. Data are
expressed as percentage of activity in the presence of vehicle alone (ethanol for farnesol and dodecanol and DMSO for C12-HSL), and values are
averages derived from four independent experiments, each performed in duplicate. Error bars represent standard error of the mean.
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both have 12-carbon backbones. Although in vivo assays have
been performed with farnesol analogues (52), we decided to
explore the generality of Cyr1p inhibition by other 12-carbon
backbone molecules. We screened a number of selected 12-
carbon molecules for their ability to directly modulate the
activity of Cyr1p in vitro. However, the majority of the com-
pounds tested did not have biological activity against Cyr1p
activation (Table 2). These data did provide insight into the
structure-activity relationship of the interaction, with the ter-
minal hydroxyl group as well as the length of the carbon chain
being important for both biochemical and biological activities.
Most importantly, these data reveal a direct correlation be-
tween the inhibitory potential of Cyr1p protein and the ability
to block filamentation.
Surprisingly, dodecanol, a 12-carbon alcohol, did not affect
the activity of Cyr1p (IC50 of 200 M) (Fig. 3C) even though
dodecanol has been shown to have QSM activity against C.
albicans hyphal formation through inhibition of cAMP signal-
ing (11). These biochemical studies suggest that 3-oxo-C12-
HSL is unique in its ability to mimic the actions of farnesol by
binding to the farnesol inhibitory site in Cyr1p, and they dem-
onstrate that although dodecanol is structurally related to
farnesol and 3-oxo-C12-HSL (12-carbon backbone) and inhib-
its C. albicans hyphal development by inhibiting cAMP signal-
ing, its mechanism of action is distinct.
Dodecanol inhibits hyphal development through Sfl1p. To
identify how dodecanol mediates its effects on hyphal devel-
opment, we screened a library of C. albicans strains containing
mutations in almost all of the known transcription factors on
hypha-inducing medium in the presence or absence of 150 M
farnesol and 200 M dodecanol. From the 158 strains tested,
only strains containing a deletion in SFL1 displayed a dode-
canol-specific, attenuated response to QSMs, with hyphal de-
velopment inhibited by farnesol but not by dodecanol.
To confirm the involvement of SFL1 in quorum sensing, an
independently constructed sfl1 strain, RAH40, was grown on
hypha-inducing medium in the presence and absence of QSMs.
RAH40 displayed an attenuated response to dodecanol, main-
taining a filamentous phenotype in the presence of 200 M
dodecanol, but remained fully responsive to farnesol. Integra-
tion of a single copy of SFL1 under its native promoter
(RAH41) was sufficient to restore the response to dodecanol
(Fig. 4A).
To identify whether QSMs differentially regulate SFL1,
semiquantitative RT-PCR was performed on total RNA ex-
tracted from the control strain exposed to methanol, 150 M
farnesol, and 200 M dodecanol. SFL1 was upregulated in
response to dodecanol, but not farnesol, compared to the sol-
vent control (Fig. 4B), further confirming the specificity of
SFL1 in the QS response to dodecanol.
Although SFL1 is described as a negative regulator of fila-
mentation, its effects are more subtle than those of Tup1p as
deletion of SFL1 does not result in constitutive filamentation
(5, 33). Therefore, the observed phenotype in response to
dodecanol is not a consequence of the strain being locked in
hyphal growth but is specifically an inability to respond to
dodecanol. Furthermore, the observation that RAH40 remains
responsive to farnesol confirms that dodecanol and farnesol
mediate their effects via distinct mechanisms.
FIG. 4. Sfl1p is required for quorum sensing in response to dode-
canol but not farnesol. (A) C. albicans strains (control, BWP17AHU
strain; sfl1, RAH40 strain; and sfl1  SFL1, RAH41 strain) were
plated onto DMEM (pH 7) with 5% serum. Plates were supplemented
with methanol, 150 M farnesol, or 200 M dodecanol and incubated
at 37°C for 24 h. Scale bar, 100 m. (B) Total RNA was extracted from
BWP17AHU grown in YPD medium supplemented with 5% serum
and either methanol, 150 M farnesol, or 200 M dodecanol for 4 h at
37°C, and SFL1 levels were determined by semiquantitative RT-PCR.
, P  0.05.
TABLE 2. Inhibition of Cyr1p activity
Compound IC50 Cyr1p activity
Range of
effective concna Reference
(E,E)-Farnesol 17 M 	1 M 25, 41
Farnesol (isomer
mix)
60 M 	3–5 M 52
Farnesoic acid Inert (250 M) 	40 Mb 52
Nerolidol 100 M 	60 M 25
Geraniol Inert (250 M) Inert 25
C12-HSL 90 M 200 M 24
C10-HSL Inert (1 mM) Inert (1 mM) 24
Decanol Inert (250 M) Inert (1 mM) 24
Dodecanol Inert (250 M) 200 M 24
Tetradecanol Inert (250 M) Inert (1 mM) 24
Dodecanoate Inert (250 M)
Decanoate Inert (250 M)
a Concentrations effective at inhibiting the yeast-to-hyphal transition in cell-
based assays, which vary depending upon growth and assay conditions, especially
the presence or absence of albumin and/or serum in medium. Where possible, we
report the values determined in the absence of albumin or serum.
b It is likely that the residual activity of farnesoic acid in vivo is due to
conversion of farnesoic acid into farnesol via endogenous alcohol dehydroge-
nases.
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Sfl1p is localized in the nucleus. Previous studies have
shown that Sfl1p is localized to the nucleus in both yeast and
hyphal cells (33). However, other reports suggest that Sfl1p is
not expressed in hyphae (5). To confirm the localization of
Sfl1p in hyphal cells, we expressed Sfl1p as a C-terminal GFP
fusion protein from the SFL1 promoter in the sfl1 strain
(RAH42). To confirm that the GFP fusion protein was func-
tional, the strain was screened on hypha-inducing medium in
the presence and absence of QSMs. RAH42 was fully respon-
sive to farnesol and dodecanol (Fig. 5A), confirming that the
fusion protein is both expressed and functional. To analyze
Sfl1p localization in both yeast and hyphal cells, RAH42 was
grown in YNB medium at 30°C to generate yeast cells and in
YNB medium supplemented with 5% serum at 37°C for hyphal
cells. Sfl1p-GFP could be visualized in the nucleus of both
yeast and hyphal cells (Fig. 5B). To determine whether Sfl1p
localization is affected by the presence of QSMs, Sfl1p-GFP
localization was assessed in the presence of 150 M farnesol or
200 M dodecanol. Sfl1p-GFP was localized in the nuclei of
cells treated with QSMs, similar to the localizations in control
samples (Fig. 5B), suggesting that these two QSMs do not
influence the localization of Sfl1p.
Dodecanol may function as an analogue of a distinct QSM.
Although dodecanol is secreted at low levels during planktonic
and biofilm growth by C. albicans and Candida dubliniensis
(39) and has QS properties (i.e., the ability to inhibit hypha
formation in C. albicans), it is currently not an established
QSM. However, as a commensal C. albicans encounters many
microorganisms which have developed QS systems, and it is
possible that dodecanol is mimicking the activity of another
biologically relevant QSM. Besides farnesol and 3-oxo-C12-
HSL, other soluble molecules containing 12-carbon backbones
have been shown to have QS activity against C. albicans hyphal
development. For example, cis-2-dodecanoic acid (Burkhold-
eria diffusible signal factor [BDSF]) secreted by B. cenocepacia
is known to inhibit C. albicans hyphal development through an
unknown mechanism (7). Therefore, we sought to identify
whether Sfl1p was required for the response to B. cenocepacia
and BDSF. Coincubation of C. albicans with B. cenocepacia
J2315, a strain that has been shown to secrete BDSF (7), under
hypha-inducing conditions confirmed that there may be a
BDSF gradient around the bacteria which inhibited C. albicans
hyphal development (Fig. 6A). This inhibition of morphogen-
esis was specific to areas surrounding B. cenocepacia as colo-
nies distal to the bacterium were fully filamentous (Fig. 6B).
However, coincubation of the sfl1 mutant in close proximity
to B. cenocepacia did not inhibit hyphal development (Fig. 6C),
and the extent of hyphal formation was similar to that in cells
FIG. 5. Sfl1p is localized to the nucleus in yeast and hyphal cells in response to quorum-sensing molecules. (A) The sfl1 mutant carrying
SFL1-GFP (RAH42) was plated onto DMEM agar (pH 7) with 5% serum. Plates were supplemented with either methanol, 150 M farnesol, or
200 M dodecanol and incubated at 37°C for 24 h. Scale bar, 100 m. (B) C. albicans strains were grown in YNB medium and YNB medium
supplemented with 5% serum in the presence or absence of farnesol and dodecanol for 2 h at 37°C. The nucleus was stained with DAPI.
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distal to the bacterium (Fig. 6D). Integration of a single copy
of SFL1 was sufficient to restore the response to the diffusible
factor produced by B. cenocepacia (Fig. 6E and F). Therefore,
we conclude that B. cenocepacia and possibly BDSF inhibit C.
albicans hyphal development through an SFL1-dependent sig-
naling pathway similar to that of dodecanol.
DISCUSSION
Colonization of host niches is the first step in establishing
infection. In mammalian hosts the mucosal surface is lined
with microbes which form the host’s natural flora. The natural
flora protects the host from infection through competition for
space and nutrients. To gain a selective advantage, some mi-
croorganisms have developed quorum-sensing systems allow-
ing them to overcome the natural flora. C. albicans is an op-
portunistic human pathogen and was the first eukaryote
identified to have a QS system. In this system, farnesol is
secreted into the environment in a biomass-dependent manner
and, once reaching threshold concentrations, inhibits the yeast-
to-hyphal transition (25). Farnesol is thought to allow the re-
lease of yeast cells from fungal biofilms, promoting the spread
of infection (43). However, the mechanism by which this occurs
is still unknown. We show here that farnesol can directly mod-
ulate the activity of the C. albicans adenylyl cyclase, reducing
cAMP output to inhibit morphogenesis. Until recently Ras1p
was suggested to be the mediator of QS in C. albicans. This
hypothesis was based on the hydrophobicity of farnesol and on
the fact that farnesol inhibits both the cAMP/PKA and Cek1p
MAPK cascades, which are activated by the actions of Ras1p.
However, we provide two lines of evidence that suggest that
Ras1p is not the main target of farnesol. First, farnesol was
able to inhibit morphogenesis induced through the actions of
CO2, which does not require Ras1p, and, second, we have
shown in vitro that farnesol is able to directly modulate the
activity of Cyr1p. Therefore, we now propose a model (Fig. 7)
whereby farnesol directly inhibits the catalytic activity of Cyr1p
to reduce cytoplasmic cAMP levels and inhibit hyphal forma-
tion. In support of this model, strains carrying alleles leading to
constitutive activation of Ras1p, which are hyperfilamentous
due to continued activation of Cyr1p, remain fully responsive
to farnesol (11).
C. albicans is also responsive to other QSMs including 3-oxo-
C12-HSL, secreted by P. aeruginosa (24). In vitro biochemical
studies confirm that this QSM also modulates the activity of
Cyr1p directly, suggesting a conserved mechanism of action for
QS in C. albicans. However, the 12-carbon alcohol dodecanol,
which has QS activity against C. albicans, did not directly mod-
ulate the activity of Cyr1p even though its mechanism of action
is dependent on the cAMP/PKA signaling cascade. However,
as purification of full-length Cyr1p was unsuccessful, we cannot
rule out that dodecanol inhibits the activity of Cyr1p at a site
distal to that of the catalytic domain. This may include the
leucine-rich region (LRR domain) which has previously been
shown to directly interact with bacterial peptidoglycan to reg-
ulate cyclase activity (58). From our in vitro assays we also
cannot rule out the involvement of effector proteins. For ex-
ample, Cap1p has recently been shown to be required for
cyclase activation under serum-inducing conditions (59). How-
ever, Cap1p is dispensable for Cyr1p activity in response to
FIG. 6. Sfl1p is required for the response to B. cenocepacia. C.
albicans was coincubated with B. cenocepacia (control, BWP17AHU
strain [A and B]; sfl1, RAH40 strain [C and D]; sfl1-SFL1, RAH41
strain [E and F]) on DMEM agar, pH 7, supplemented with 5% serum
for 24 h at 37°C. Images were taken of C. albicans cells in close
proximity (top row) and distal to B. cenocepacia (bottom row). Arrow-
heads identify B. cenocepacia. Scale bar, 100 m.
FIG. 7. Schematic representation of how quorum-sensing mole-
cules affect the C. albicans cAMP/PKA-dependent signaling cascade
(see text for details).
1040 HALL ET AL. EUKARYOT. CELL
 o
n
 M
ay 6, 2015 by University of Birm
ingham
http://ec.asm
.org/
D
ow
nloaded from
 
CO2 (59), suggesting that any role played by Cap1p in response
to QSMs is likely to be minor.
Dodecanol appears to inhibit hyphal development through a
cAMP-dependent pathway involving the transcriptional hyphal
suppressor Sfl1p (Fig. 7). Therefore, Cyr1p may be only one of
the receptors responsible for QS in C. albicans. In agreement
with this, global transcriptional approaches and phenotypical
screens have identified that the Cek1p MAPK, Tup1p, and the
two-component histidine kinase cascade function in QS (26,
29, 46, 47). Although it is possible that QSMs affect multiple
pathways, basal concentrations of cAMP are required for ac-
tivation of these pathways, making it hard to deduce the role
each pathway plays. Furthermore, as molecular mechanisms
are dissected in detail, more cross talk between the pathways is
emerging. For example, the cAMP/PKA pathway has recently
been shown to regulate the phosphorylation of Hog1p (12).
Therefore, inhibition of the cAMP/PKA pathway may impact
the Cek1p-MAPK and Tup1p pathways through interactions
which are currently unidentified. In agreement with this, Sfl1p
is known to interact with Ssn6p to recruit the Ssn6p-Tup1p
regulatory complex to promoters in Saccharomyces cerevisiae
(9). Interactions between Sfl1p and the Ssn6p-Tup1p complex
in C. albicans have not been studied. Therefore, it is possible
that Tup1p’s involvement in QS is due to disruption of the
Sfl1p-Ssn6p-Tup1p complex. However, the tup1 mutant does
not respond to either farnesol or dodecanol (26), suggesting
that Tup1p plays another role in response to farnesol.
Mosel et al. have shown that farnesol is effective in inhibiting
C. albicans morphogenesis at concentrations below 5 M un-
der certain conditions (41). However, our biochemical studies
suggest that the IC50 of Cyr1p for farnesol is 17 M. Although
the IC50 may appear higher than concentrations found in vivo,
our experiments were performed on a truncated protein in
which several domains were absent that might be required for
a full response to QS. Therefore, it might be possible that
full-length Cyr1p would exhibit an IC50 nearer to in vivo con-
centrations. In addition, in in vivo situations QSMs appear to
work by affecting several pathways (see above), so it may be
possible that under these circumstances, where all components
of every pathway are present, QS occurs at a much lower
concentration.
Farnesol is toxic to a number of organisms as a result of the
production and accumulation of reactive oxygen species (ROS)
(34, 48, 49). ROS generation is due to inhibition of the electron
transport chain (37, 38), suggesting that farnesol targets the
mitochondria. Although it has been reported that farnesol is
not toxic to C. albicans (11, 25), farnesol can still promote ROS
generation (53) and have toxic side effects on C. albicans (30).
Recently, it has been shown that farnesol can enhance resis-
tance to ROS (12, 57). Initially the enhanced resistance was
hypothesized to be a result of the elevated ROS inducing the
expression of genes essential for ROS protection. However,
Deveau et al. recently showed that the ROS generation by
farnesol is not required for farnesol’s impact on oxidative
stress resistance (12). Here, we provide evidence that dode-
canol, which has QSM activity against C. albicans, also en-
hanced oxidative stress resistance in C. albicans, suggesting
that other QSMs may enhance C. albicans protection against
ROS.
In the human host, potential outbreaks of C. albicans are
controlled by circulating phagocytes, which kill the pathogen
through the release of high concentrations of ROS. Therefore,
infections resulting in an accumulation of fungal biomass, for
example, in esophageal candidiasis, may be more resistant to
phagocyte killing due to increased resistance to ROS provided
by the elevated concentration of farnesol. Moreover, C. albi-
cans infections can be a mixture of fungal and bacterial species.
For example, in cystic fibrosis patients C. albicans is routinely
isolated from the lungs along with P. aeruginosa and B. ceno-
cepacia (3, 6, 19, 44), both of which produce QSMs with activity
against C. albicans (7, 24). Therefore, the combination of
QSMs present may affect the ability of the circulating phago-
cytes to kill C. albicans. In agreement with this, QSMs have
been shown to inhibit macrophage ROS production and induc-
tion of macrophage apoptosis (1). Therefore, QSMs play es-
sential roles in morphogenesis, stress resistance, and virulence
through modulation of the C. albicans cAMP/PKA pathway.
Further understanding of the molecular mechanisms of other
QSMs (including the DSF, BDSF, and SDSF secreted by Xan-
thomonas campestris, B. cenocepacia, and Streptococcus spe-
cies, respectively) on C. albicans morphogenesis will enhance
our understanding of interkingdom communication and shed
light on the effects QSMs may have on the immune response
(7, 54, 56).
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